Drug Development Pipeline for Rare Metabolic Disorders: Focus on Methylmalonic Acidemia and the Evolving Therapeutic Landscape
Rare metabolic disorders such as methylmalonic acidemia (MMA) represent a significant unmet medical need in modern healthcare. Characterized by the body’s inability to properly break down certain proteins and fats, MMA leads to toxic metabolite accumulation and...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek